TAIWAN · TWSE / TPEx
TAHO Pharma
泰合 · 6467 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$199.001 month -19.3% · 1 year +20.6%
Directors and supervisors hold6,319,20312.1% of shares issued
Of which pledged0.0%0
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 李世仁 | Chairman · President | 612,517 | 655,017 | 1.25% | — | — |
| 江明衛 | Director | 3,381,760 | 3,733,186 | 7.12% | — | — |
| 洪素芬 | Director | 1,857,000 | 1,885,000 | 3.60% | — | — |
| 信東生技股份有限公司 | Director | 56,000 | 46,000 | 0.09% | — | — |
| 柯彥輝 | Director (corporate representative) | — | 0 | — | — | — |
| 朱紀洪 | Independent director | — | 0 | — | — | — |
| 葛之剛 | Independent director | — | 0 | — | — | — |
| 馮震宇 | Independent director | — | 0 | — | — | 7,000 |
| 劉克宜 | Independent director | — | 0 | — | — | — |
| 李苑琳 | Assistant vice president | — | 54,000 | 0.10% | — | — |
| 蔡佩容 | Chief financial officer · Chief accountant · Other | — | 12,195 | 0.02% | — | — |